glp-1 receptor agonist diarrhea management semaglutide Semaglutide is a FDA-approved used to improve blood sugar GLP-1 for Crohn's Disease: Current
Description
These groups do not represent contraindications for GLP-1RA therapy
Retatrutide should be considered a second-line or specialized first-line agent for complex cases once it gains regulatory approval
2025, doi: 10.1016/j.ajcnut.2025.04.023
Obesity can promote the growth of breast cancer
doi: 10.1111/dom.13979 118 JastreboffAMAronneLJAhmadNNWhartonSConneryLAlvesBet al
Clinical Trial Data on GLP-1 Side Effects Beyond effects on the stomach, there have been concerns in the community about repercussions for other organs, chief among them being the pancreatitis that Zarghamis physician had warned her about
